Department of Chemical Engineering, Research Center for High Performance Polymer and Composite Systems (CREPEC), Polytechnique Montréal, Montréal H3C 3A7 Québec, Canada.
Center for Research in Radiotherapy, Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4 Québec, Canada.
Biomed Mater. 2024 Jun 26;19(4). doi: 10.1088/1748-605X/ad581b.
Glioblastoma (GBM) accounts for half of all central nervous system tumors. Once the tumor is removed, many GBM cells remain present near the surgical cavity and infiltrate the brain up to a distance of 20-30 mm, resulting in recurrence a few months later. GBM remains incurable due to the limited efficiency of current treatments, a result of the blood-brain barrier and sensitivity of healthy brain tissues to chemotherapy and radiation. A new therapeutic paradigm under development to treat GBM is to attract and accumulate GBM cells in a cancer cell trap inserted in the surgical cavity after tumor resection. In this work, porous gels were prepared using porous polylactide molds obtained from melt-processed co-continuous polymer blends of polystyrene and polylactide, with an average pore size ranging from 5 μm to over 500 μm. In order to efficiently accumulate and retain GBM brain cancer cells within a macroporous sodium alginate-based hydrogel trap, the pores must have an average diameter superior to 100 μm, with the best results obtained at 225 μm. In that case, the accumulation and retention of F98 GBM cells were more homogeneous, especially when functionalized with RGD adhesion peptides. At an alginate concentration of 1% w/v, the compression modulus reaches 15 kPa, close to the average value of 1-2 kPa reported for brain tissues, while adhesion and retention were also superior compared to 2% w/v gels. Overall, 1% w/v gels with 225 μm pores functionalized with the RGD peptide display the best performances.
胶质母细胞瘤(GBM)占中枢神经系统肿瘤的一半。肿瘤切除后,许多 GBM 细胞仍存在于手术腔附近,并浸润大脑,距离可达 20-30 毫米,导致几个月后复发。由于目前治疗方法的效率有限,血脑屏障和健康脑组织对化疗和放疗的敏感性,GBM 仍然无法治愈。一种新的治疗胶质母细胞瘤的治疗模式是在肿瘤切除后将癌细胞陷阱插入手术腔中,以吸引和聚集 GBM 细胞。在这项工作中,使用从聚苯乙烯和聚乳酸共连续聚合物共混物的熔融加工中获得的多孔聚乳酸模具制备多孔凝胶,平均孔径范围从 5μm 到 500μm 以上。为了在基于大孔海藻酸钠的水凝胶陷阱中有效地聚集和保留 GBM 脑癌细胞,孔的平均直径必须大于 100μm,最好的结果是 225μm。在这种情况下,F98 GBM 细胞的聚集和保留更加均匀,特别是当用 RGD 粘附肽功能化时。在 1%w/v 的海藻酸钠浓度下,压缩模量达到 15kPa,接近 1-2kPa 的脑组织平均值,而与 2%w/v 凝胶相比,粘附和保留也更好。总体而言,用 RGD 肽功能化的 1%w/v 凝胶具有 225μm 的孔显示出最佳性能。